• HOME
  • About
    • Leadership
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
  • Contact
    Careers News

We are now part of invoX Pharma

    Careers News
  • About
    • Leadership
    • Pharmaceutical Partnerships
    • Meet F-Star Team Members
  • Technology
    • Our Platform
    • Publications
    • Intellectual Property
  • Pipeline
    • FS118
    • FS120
    • FS222
    • SB 11285
  • Contact

Press Releases

Feb 20, 2020

F-star Therapeutics to Participate in the BTIG Targeted Therapeutics Conference »

Jan 30, 2020

F-star Therapeutics Announces FDA Acceptance of IND Application for FS120 »

Jan 9, 2020

F-star Therapeutics Appoints Dr. Edward Benz and Mr. Geoff Race to Board of Directors »

Nov 8, 2019

F-star Presents New Data on OX40/CD137 Tetravalent Bispecific Antibody at the SITC 2019 Annual Meeting »

Jun 18, 2019

F-star appoints Darlene Deptula-Hicks as CFO »

Jun 10, 2019

F-star appoints Dr Louis Kayitalire as CMO »

May 30, 2019

F-star updates on FS118 clinical trial and announces presentation at ASCO 2019 »

May 14, 2019

F-star expedites its transition to a wholly-owned portfolio strategy »

Mar 25, 2019

F-star Presents New Data on its Tetravalent Bispecific Antibodies at the AACR 2019 Annual Meeting »

Nov 29, 2018

F-star Wins “Best Partnership Alliance” Award at the 14th Annual Scrip Awards Ceremony »

Nov 1, 2018

F-star to Disclose Targets and Preclinical Data on New Agonist Bispecific Antibody Programmes »

Oct 15, 2018

F-star Appoints Dr Eliot Forster as Chief Executive Officer »

Sep 10, 2018

F-star Appoints Nessan Bermingham as Chairman of its Board of Directors »

Jul 24, 2018

F-star Announces the Achievement of a Clinical Milestone in its Immuno-Oncology Collaboration with Merck »

May 30, 2018

F-star Announces Early Exercise by Denali Therapeutics of its Option to Acquire F-star Gamma »

May 21, 2018

F-star Announces First Patient Dosed in Phase I Clinical Trial of FS118, a First-in-class Immuno-oncology Bispecific Antibody »

Apr 9, 2018

F-star to Present New Preclinical Data on FS118, a First-in-Class Immuno-Oncology Bispecific Antibody, at the AACR 2018 Annual Meeting »

Jan 9, 2018

F-star Provides an Update on its Collaboration with Denali Therapeutics »

Sep 22, 2017

F-star Recognised as a Finalist in Two Categories of the Scrip Awards 2017 »

Sep 15, 2017

F-star Wins “UK Life Sciences Deal of the Year” and “UK Life Sciences CEO of the Year” at the Biotech and Money 2017 Awards »

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
Year

About 

Overview Leadership Board of Directors Pharmaceutical Partnerships

Technology 

Overview Our Platform Publications Intellectual Property

Pipeline 

Program Overview FS118 FS120 FS222 SB 11285

 

Investors Careers News Contact Us

Eddeva B920
Babraham Research Campus
Cambridge, CB22 3AT, UK

245 First Street
Riverview II, Floor 18
Cambridge, MA 02142, USA

Disclaimer Privacy Policy Cookie Policy Careers Sitemap

© 2023 F-Star Therapeutics Inc.

We use cookies to give you the best online experience. Please see our cookie policy here. Please let us know if you agree to all of these cookies.
Accept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT